AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

🇳🇬

Losartan Potassium; Hydrochlorothiazide in Nigeria

12 products registered with NAFDAC 12 active

Brand / ProductReg. No.HolderStatusExpires
Synermed Losartan Potassium 50 mg and Hydrochlorothiazide 12.5 mg Tablets_
Tablet
A4-101509Synermed Nig Ltdactive26 Aug 2030
Lorzide Tablet
Tablet
B4-7995Unosource Pharma Nigeria Limitedactive30 Oct 2028
Angizaar H Tablets**
Tablet
A4-5839Micro Nova Pharmaceuticals Ind Ltdactive5 Jul 2028
CoLosar-Denk 50/12.5 mg Tablets**
Tablet
B4-5167Assene-Laborex Limitedactive25 Aug 2026
Artazide Tablet (duplicate)
Tablet
B4-4353Preferred Drugs Nigeria Limitedactive25 Aug 2026
Presartan H50 Tablets
Tablet
A4-2315IPCA Pharma Nigeria Limitedactive2 Aug 2026
Losakind-50 H Tablets
Tablet
B4-1130Phillips Pharmaceuticals (Nigeria) Limitedactive27 Jan 2026
Rista H Tablet 50/12.5
Tablet
C4-1352Dony-Triumph and Company Nigeria Limitedactive20 Dec 2025
Rista H Tablet 100/25
Tablet
C4-1353Dony-Triumph and Company Nigeria Limitedactive20 Dec 2025
Nusar-H Tablets (null smpc)
Tablet
A4-5143Emcure Nigeria Limitedactive20 Dec 2025
Asartan-H Tablets
Tablet
B4-1655Astranad Pharmaceuticals and Chemical Company Limitedactive9 Nov 2025
Losatrust-H Tablets
Tablet
A4-2814Al-Tinez Pharmaceuticals Limitedactive9 Nov 2025

Losartan Potassium; HydrochlorothiazideNAFDAC Registration Details

NAFDAC (Nigeria) has 12 registered products containing Losartan Potassium; Hydrochlorothiazide, of which 12 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.

Track Losartan Potassium; Hydrochlorothiazide registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.